Revenue
No reported data
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Research & development | $12.5M | $8.7M | $6.8M | $7.3M | $4.1M | $1.9M | $788,000 | $32.5M | $4.6M |
| Operating expenses | — | — | — | — | — | $134,000 | $124,000 | $492,000 | $9.2M |
| Operating income | −$18.2M | −$16.6M | −$15.6M | −$12.4M | −$6.0M | −$2.8M | −$2.2M | −$35.5M | — |
| EBITDAderived | −$18.1M | −$16.6M | — | — | — | — | — | — | — |
| Net income | −$75.3M | −$104.6M | −$16.9M | −$15.8M | −$5.3M | −$2.6M | $123.7M | $16.3M | −$5.7M |
| Basic EPSper diluted share | -$77.83 | -$129.79 | -$1.29 | — | -$0.49 | -$0.55 | $46.21 | $0.06 | -$0.02 |
| Diluted EPSper diluted share | -$77.83 | -$129.79 | -$1.29 | — | -$0.49 | -$0.55 | $45.89 | $0.06 | -$0.02 |